Results 141 to 150 of about 168,874 (243)

Guidelines for the Endoscopic Diagnosis of Ulcerative Colitis Are Not Followed in a Substantial Proportion of Patients: Real‐World Use of Colonoscopy Versus Sigmoidoscopy—A Copenhagen Inflammatory Bowel Disease Inception Cohort Study

JCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Background and Aims Evaluating whether international endoscopic diagnostic guideline recommendations regarding ulcerative colitis are followed in routine clinical practice, and assessing the clinical value of performing a follow‐up ileocolonoscopy in patients diagnosed based on a sigmoidoscopy.
Clara Mille Frøsig Bendsen, Trine Velte Honoré, Cathrine Olesen Emborg, Gorm Roager Madsen, Mohamed Attauabi, Flemming Bendtsen, Jakob Benedict Seidelin, Johan Burisch   +7 more
wiley   +1 more source

Inflammatory Bowel Disease: Mechanisms and Therapeutic Advances

MedComm, Volume 7, Issue 9, September 2026.
Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn's disease, is a rising, multifactorial chronic disorder driven by dysregulated mucosal immunity in genetically susceptible individuals and influenced by environmental and microbial factors.
Andrea Papait, Anna Cargnoni, Franco Scaldaferri, Loris Lopetuso, Antonietta Rosa Silini, Ornella Parolini   +5 more
wiley   +1 more source

Microbial Signals in Cancer: Dissecting Host–Microbiota–Tumor Interactions and Potential Therapeutic Strategy

MedComm, Volume 7, Issue 9, September 2026.
Microbial signals from gut and tumor‐resident bacteria, fungi, viruses, and bacteriophages reshape immune and metabolic networks within the tumor microenvironment, thereby influencing cancer progression, treatment response. Therapeutic modulations, including dietary interventions, probiotics, antibiotics, fecal microbiota transplantation, engineered ...
Juan Lu, Mengjuan Xuan, Liang Yu, Zhongyang Xie, Qingfei Chu, Shihui Wei, Tuokai Wang, Chen Xue, Lanjuan Li   +8 more
wiley   +1 more source

Risk factors for further recurrences of Clostridioides difficile infection at the first and second recurrence: a retrospective cohort

BMC Infectious Diseases
Background Recurrent Clostridioides difficile infection is most effectively treated with faecal microbiota transplantation. Swedish and European guidelines suggest faecal microbiota transplantation after a first or second recurrence, respectively.
Måns Stefansson, Oscar Bladh, Piotr Nowak, Lars Rombo, Magnus Hedenstierna, Johan Ursing   +5 more
doaj   +1 more source

Multiplex PCR to Diagnose Gastrointestinal Infections: Key Limitations in Interpretation

United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.
ABSTRACT Multiplex polymerase chain reaction (PCR) panels are increasingly used for the evaluation of acute diarrhea, providing rapid and sensitive detection of a broad range of enteric pathogens. However, their widespread adoption has created important interpretive challenges for clinicians.
Giannoula S. Tansarli, Ferric C. Fang
wiley   +1 more source

A Review of Therapies for Clostridioides difficile Infection

Antibiotics
Clostridioides difficile is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of Clostridioides difficile infection (CDI), it remains a ...
Faiza Morado, Neha Nanda
doaj   +1 more source

Patterns of Surgical Prophylaxis Prescribing for Dentoalveolar Procedures in Australian Hospitals: 2016–2022

Australian Dental Journal, Volume 71, Issue 3, Page 231-241, September 2026.
ABSTRACT Background Antimicrobials are an adjunctive therapy in clinical dentistry. In dentoalveolar surgery, antimicrobials are not routinely required for surgical prophylaxis. This retrospective analysis of the Australian Surgical National Antimicrobial Prescribing Survey (Surgical NAPS) dataset aimed to evaluate the guideline compliance and ...
Jane Chen, Marietta Taylor, Rodney James, Karin Thursky, Michael McCullough, Leanne Teoh, Courtney Ierano   +6 more
wiley   +1 more source

Dominance of toxigenic Clostridioides difficile strains and the appearance of the emerging PCR ribotype 955 in hospitals in Silesia, Poland

Frontiers in Microbiology
IntroductionToxigenic strains of Clostridioides difficile are the leading cause of healthcare-associated bacterial infections in Poland. In the Silesian Voivodeship, with 4.5 million inhabitants, the incidence of C.
Klaudia Szarek, Natalia Frankowska, Natalia Frankowska, Monika Kabała, Wiep Klaas Smits, Dorota Wultańska, Piotr Lalowski, Hanna Pituch, Adam Iwanicki, Krzysztof Hinc, Céline Harmanus, Ingrid M. J. G. Sanders, Robert Wojtyczka, Tomasz J. Wąsik   +13 more
doaj   +1 more source

Механизмы антибактериальной резистентности Clostridium (clostridioides) difficile

Aim of the review. To study and consolidate recent data on Clostridium (Clostridioides) difficile antibacterial resistance mechanisms. Key points. There is objective data about the spread of antimicrobial resistant Clostridium (Clostridioides) difficile ...
Makesheva A.B., Kashnikov V.N., Sukhina M.A., Shelygin Y.A.   +3 more
core   +1 more source

Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 6, Page 729-747, September 2026.
The gut microbiome modulates ulcerative colitis pharmacotherapy through microbial drug metabolism, immune regulation and altered drug bioavailability. Microbial composition influences response to aminosalicylates, corticosteroids, immunomodulators, biologics and small molecules, while microbiome‐targeted therapies show emerging promise.
Kate Collins, Srinivas Kamath, Rachel H. Davis, Samuel P. Costello, Robert V. Bryant, Alice S. Day, Paul Joyce   +6 more
wiley   +1 more source